This is a preview of subscription content, log in via an institution to check access.
References
Bauer FW, Crombag NHCMN, de Grood RM, Boezeman JB (1980) Quantification of deviations of the epidermal DNA-distributions in psoriasis and the effect of therapy. In: Laerum OD, Lindmo T, Thourd E (eds) Flow cytometry. Universiteitsforlaget, Bergen Oslo Trondheim, pp 377–381
Christophers E, Braun-Falco O (1970) Psoriatic hyperplasia: some measurements. Br J Dermatol 83:63–68
Jong EMGJ de, Kerkhof PCM van de (1991) Simultaneous assessment of inflammation and epidermal proliferation in psoriatic plaques during treatment with the vitamin D3 analogue MC903: modulations and interrelations. Br J Dermatol 124:221–229
Mare S de, Calis N, Hartog G de, Erp PEJ van, Kerkof PCM van de (1988) The relevance of salicylic acid in the treatment of plaque psoriasis with dithranol creams. Skin Pharmacol 1:259–264
Mare S de, Jong EMGJ de, Erp PEJ van, Kerkhof PCM van de (1990) DNA content and Ks8.12 binding of the psoriatic lesion during treatment with the vitamin D3 analogue MC903 and betamethasone. Br J Dermatol 3:291–295
Griffith TD, Lattanand A, Van Scott J (1988) Clinical and histologic heterogeneity of psoriatic plaques. Therapeutic relevance. Arch Dermatol 124:216–220
Holland DB, Wood EJ, Cunliffe WJ, West MR, Turner DM (1987) Effect of different therapeutic regimes on epidermal keratins in psoriasis (abstract). J Invest Dermatol 89:328
Moll R, Franke WW, Volc-Platzer B, Krepler R (1982) Different keratin polypeptides in epidermis and other epithelia of human skin: a specific cytokeratin of molecular weight 46,000 in epithelia of the pilosebaceous tract and basal cell epitheliomas. J Cell Biol 95:285–289
Moll R, Franke WW, Schiller DL, Geiger B, Krepler R (1982) The catalog of human cytokeratins: patterns of expression in normal epithelia, tumours and cultured cells. Cell 31:11–24
Pinkus H, Mehregan AH (1966) The primary histologic lesion of seborrhoeic dermatitis and psoriasis. J Invest Dermatol 46:109–116
Soltani K, Van Scott EJ (1972) patterns and sequence of tissue changes in incipient and evolving lesions of psoriasis. Arch Dermatol 106:484–490
Troyanovski SM, Guelstein VCI, Tchipysheva TA, Krutovskikh VA, Bannikov GA (1989) Patterns of expression of keratin 17 in human epithelia: dependency on cell position. J Cell Sci 93:419–426
Erp PEJ van, Mare S de, Rijzewijk JJ, Kerkof PCM van de, Bauer FW (1989) A sequential double immunoenzymic staining procedure to obtain cell kinetic information in normal and hyperproliferative epidermis. Histochem J 21:343–347
Erp PEJ van, Rijzewijk JJ, Boezeman JBM, Leenders J, Mare S de, Schalkwijk J, Kerkhof PCM van de, Ramaekers FCS, Bauer FW (1989) Flow cytometric analysis of epidermal sub-populations from normal and psoriatic skin using monoclonal antibodies against intermediate filaments. Am J Pathol 135:865–870
Weiss RA, Eichner R, Sun TT (1984) Monoclonal antibody analysis of keratin expression in epidermal diseases: a 48- and 56-kDalton keratin as molecular markers for hyperproliferative keratinocytes. J Cell Biol 98:1397–1406
Wilson CL, Deane D, Wojnarowska F, Lane EB, Leigh IM (1990) Follicular keratin expression in normal and psoriatic scalp (abstr). J Invest Dermatol 95:495
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
de Jong, E.M.G.J., van Vlijmen, I.M.M.J., van Erp, P.E.J. et al. Keratin 17: a useful marker in anti-psoriatic therapies. Arch Dermatol Res 283, 480–482 (1991). https://doi.org/10.1007/BF00371788
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00371788